Global Huntington's Disease Therapeutics Market Insights, Forecast to 2025

Publisher Name :
Date: 31-May-2019
No. of pages: 115
Inquire Before Buying

Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease.

The demand for Huntington's disease (HD) therapeutics as one of the primary growth factors for the Huntington's disease therapeutics market. HD is equally prevalent in both males and females and affects people irrespective of their ethnicity. The disease symptoms may appear anytime in the individual's life and the etiology is genetic. The person who inherits the mutated genes from their affected parents will probably suffer from the disease sometime in their lifetime.

The Americas is witnessing increasing incidences of HD. The availability of increased patient pool and the rise in government initiatives boost the research and development of novel therapeutics for the treatment of HD. The rising investments towards the launch of new drugs for the treatment of chorea will positively influence the growth of the Huntington's disease therapeutics market in this region.

The global Huntington's Disease Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Huntington's Disease Therapeutics market based on company, product type, end user and key regions.

This report studies the global market size of Huntington's Disease Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Huntington's Disease Therapeutics in these regions.

This research report categorizes the global Huntington's Disease Therapeutics market by top players/brands, region, type and end user. This report also studies the global Huntington's Disease Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- F. Hoffmann-La Roche

- H. Lundbeck

- Prana Biotechnology

- Teva Pharmaceutical Industries

- Horizon Pharma

Market size by Product

- Antidopaminergics

- Anticonvulsants

- Antipsychotics

- Antidepressants

Market size by End User

- Hospitals

- Clinics

- Diagnostic Centers

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Huntington's Disease Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Huntington's Disease Therapeutics market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Huntington's Disease Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Huntington's Disease Therapeutics submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Huntington's Disease Therapeutics are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Huntington's Disease Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Huntington's Disease Therapeutics Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Huntington's Disease Therapeutics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Huntington's Disease Therapeutics Market Size Growth Rate by Product
1.4.2 Antidopaminergics
1.4.3 Anticonvulsants
1.4.4 Antipsychotics
1.4.5 Antidepressants
1.5 Market by End User
1.5.1 Global Huntington's Disease Therapeutics Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Huntington's Disease Therapeutics Market Size
2.1.1 Global Huntington's Disease Therapeutics Revenue 2014-2025
2.1.2 Global Huntington's Disease Therapeutics Sales 2014-2025
2.2 Huntington's Disease Therapeutics Growth Rate by Regions
2.2.1 Global Huntington's Disease Therapeutics Sales by Regions
2.2.2 Global Huntington's Disease Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Huntington's Disease Therapeutics Sales by Manufacturers
3.1.1 Huntington's Disease Therapeutics Sales by Manufacturers
3.1.2 Huntington's Disease Therapeutics Sales Market Share by Manufacturers
3.1.3 Global Huntington's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Huntington's Disease Therapeutics Revenue by Manufacturers
3.2.1 Huntington's Disease Therapeutics Revenue by Manufacturers (2014-2019)
3.2.2 Huntington's Disease Therapeutics Revenue Share by Manufacturers (2014-2019)
3.3 Huntington's Disease Therapeutics Price by Manufacturers
3.4 Huntington's Disease Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Huntington's Disease Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Huntington's Disease Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Huntington's Disease Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Huntington's Disease Therapeutics Sales by Product
4.2 Global Huntington's Disease Therapeutics Revenue by Product
4.3 Huntington's Disease Therapeutics Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Huntington's Disease Therapeutics Breakdown Data by End User
6 North America
6.1 North America Huntington's Disease Therapeutics by Countries
6.1.1 North America Huntington's Disease Therapeutics Sales by Countries
6.1.2 North America Huntington's Disease Therapeutics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Huntington's Disease Therapeutics by Product
6.3 North America Huntington's Disease Therapeutics by End User
7 Europe
7.1 Europe Huntington's Disease Therapeutics by Countries
7.1.1 Europe Huntington's Disease Therapeutics Sales by Countries
7.1.2 Europe Huntington's Disease Therapeutics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Huntington's Disease Therapeutics by Product
7.3 Europe Huntington's Disease Therapeutics by End User
8 Asia Pacific
8.1 Asia Pacific Huntington's Disease Therapeutics by Countries
8.1.1 Asia Pacific Huntington's Disease Therapeutics Sales by Countries
8.1.2 Asia Pacific Huntington's Disease Therapeutics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Huntington's Disease Therapeutics by Product
8.3 Asia Pacific Huntington's Disease Therapeutics by End User
9 Central & South America
9.1 Central & South America Huntington's Disease Therapeutics by Countries
9.1.1 Central & South America Huntington's Disease Therapeutics Sales by Countries
9.1.2 Central & South America Huntington's Disease Therapeutics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Huntington's Disease Therapeutics by Product
9.3 Central & South America Huntington's Disease Therapeutics by End User
10 Middle East and Africa
10.1 Middle East and Africa Huntington's Disease Therapeutics by Countries
10.1.1 Middle East and Africa Huntington's Disease Therapeutics Sales by Countries
10.1.2 Middle East and Africa Huntington's Disease Therapeutics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Huntington's Disease Therapeutics by Product
10.3 Middle East and Africa Huntington's Disease Therapeutics by End User
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 Company Business Overview
11.1.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 F. Hoffmann-La Roche Huntington's Disease Therapeutics Products Offered
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 H. Lundbeck
11.2.1 H. Lundbeck Company Details
11.2.2 Company Business Overview
11.2.3 H. Lundbeck Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 H. Lundbeck Huntington's Disease Therapeutics Products Offered
11.2.5 H. Lundbeck Recent Development
11.3 Prana Biotechnology
11.3.1 Prana Biotechnology Company Details
11.3.2 Company Business Overview
11.3.3 Prana Biotechnology Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Prana Biotechnology Huntington's Disease Therapeutics Products Offered
11.3.5 Prana Biotechnology Recent Development
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Details
11.4.2 Company Business Overview
11.4.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Products Offered
11.4.5 Teva Pharmaceutical Industries Recent Development
11.5 Horizon Pharma
11.5.1 Horizon Pharma Company Details
11.5.2 Company Business Overview
11.5.3 Horizon Pharma Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Horizon Pharma Huntington's Disease Therapeutics Products Offered
11.5.5 Horizon Pharma Recent Development
12 Future Forecast
12.1 Huntington's Disease Therapeutics Market Forecast by Regions
12.1.1 Global Huntington's Disease Therapeutics Sales Forecast by Regions 2019-2025
12.1.2 Global Huntington's Disease Therapeutics Revenue Forecast by Regions 2019-2025
12.2 Huntington's Disease Therapeutics Market Forecast by Product
12.2.1 Global Huntington's Disease Therapeutics Sales Forecast by Product 2019-2025
12.2.2 Global Huntington's Disease Therapeutics Revenue Forecast by Product 2019-2025
12.3 Huntington's Disease Therapeutics Market Forecast by End User
12.4 North America Huntington's Disease Therapeutics Forecast
12.5 Europe Huntington's Disease Therapeutics Forecast
12.6 Asia Pacific Huntington's Disease Therapeutics Forecast
12.7 Central & South America Huntington's Disease Therapeutics Forecast
12.8 Middle East and Africa Huntington's Disease Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Huntington's Disease Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Huntington's Disease Therapeutics Product Picture
Table Huntington's Disease Therapeutics Market Segments
Table Key Manufacturers Huntington's Disease Therapeutics Covered
Table Global Huntington's Disease Therapeutics Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Huntington's Disease Therapeutics Sales Market Share by Product 2014-2025
Figure Antidopaminergics Product Picture
Table Major Manufacturers of Antidopaminergics
Figure Anticonvulsants Product Picture
Table Major Manufacturers of Anticonvulsants
Figure Antipsychotics Product Picture
Table Major Manufacturers of Antipsychotics
Figure Antidepressants Product Picture
Table Major Manufacturers of Antidepressants
Table Global Huntington's Disease Therapeutics Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Hospitals
Figure Clinics
Figure Diagnostic Centers
Figure Huntington's Disease Therapeutics Report Years Considered
Figure Global Huntington's Disease Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Huntington's Disease Therapeutics Sales 2014-2025 (K MT)
Table Global Huntington's Disease Therapeutics Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Huntington's Disease Therapeutics Sales by Regions 2014-2019 (K MT)
Table Global Huntington's Disease Therapeutics Sales Market Share by Regions 2014-2019
Figure Global Huntington's Disease Therapeutics Sales Market Share by Regions 2014-2019
Figure 2018 Global Huntington's Disease Therapeutics Sales Market Share by Regions
Table Global Huntington's Disease Therapeutics Revenue by Regions 2014-2019 (Million US$)
Table Global Huntington's Disease Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Huntington's Disease Therapeutics Revenue Market Share by Regions 2014-2019
Figure 2018 Global Huntington's Disease Therapeutics Revenue Market Share by Regions
Table Global Huntington's Disease Therapeutics Sales by Manufacturers (2014-2019) (K MT)
Table Global Huntington's Disease Therapeutics Sales Share by Manufacturers (2014-2019)
Figure Global Huntington's Disease Therapeutics Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Huntington's Disease Therapeutics Revenue by Manufacturers (2014-2019) (Million USD)
Table Huntington's Disease Therapeutics Revenue Share by Manufacturers (2014-2019)
Figure Huntington's Disease Therapeutics Value Share by Manufacturers in 2018
Table Key Manufacturers Huntington's Disease Therapeutics Price (2014-2019) (USD/MT)
Table Huntington's Disease Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Huntington's Disease Therapeutics Product Type
Table Date of International Manufacturers Enter into Huntington's Disease Therapeutics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Huntington's Disease Therapeutics Sales by Product (2014-2019) (K MT)
Table Global Huntington's Disease Therapeutics Sales Share by Product (2014-2019)
Figure Global Huntington's Disease Therapeutics Sales Market Share by Product (2014-2019)
Figure Global Huntington's Disease Therapeutics Sales Market Share by Product in 2018
Table Global Huntington's Disease Therapeutics Revenue by Product (2014-2019) (Million US$)
Table Global Huntington's Disease Therapeutics Revenue Share by Product (2014-2019)
Figure Global Huntington's Disease Therapeutics Revenue Market Share by Product (2014-2019)
Figure Global Huntington's Disease Therapeutics Revenue Market Share by Product in 2018
Table Huntington's Disease Therapeutics Price by Product 2014-2019 (USD/MT)
Table Global Huntington's Disease Therapeutics Sales by End User (2014-2019) (K MT)
Table Global Huntington's Disease Therapeutics Sales Share by End User (2014-2019)
Figure Global Sales Huntington's Disease Therapeutics Market Share by End User (2014-2019)
Figure Global Sales Huntington's Disease Therapeutics Market Share by End User in 2018
Figure North America Huntington's Disease Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure North America Huntington's Disease Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Huntington's Disease Therapeutics Sales by Countries (2014-2019) (K MT)
Table North America Huntington's Disease Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 North America Huntington's Disease Therapeutics Sales Market Share by Countries
Table North America Huntington's Disease Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table North America Huntington's Disease Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Huntington's Disease Therapeutics Revenue Market Share by Countries
Figure United States Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure United States Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Canada Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table North America Huntington's Disease Therapeutics Sales by Product (2014-2019) (K MT)
Table North America Huntington's Disease Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 North America Huntington's Disease Therapeutics Market Share by Product
Table North America Huntington's Disease Therapeutics Sales by End User (2014-2019) (K MT)
Table North America Huntington's Disease Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 North America Huntington's Disease Therapeutics Market Share by End User
Figure Europe Huntington's Disease Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure Europe Huntington's Disease Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Huntington's Disease Therapeutics Sales by Countries (2014-2019) (K MT)
Table Europe Huntington's Disease Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Huntington's Disease Therapeutics Sales Market Share by Countries
Table Europe Huntington's Disease Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Europe Huntington's Disease Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Huntington's Disease Therapeutics Revenue Market Share by Countries
Figure Germany Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Germany Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure France Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure France Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure UK Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Italy Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Russia Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Huntington's Disease Therapeutics Sales by Product (2014-2019) (K MT)
Table Europe Huntington's Disease Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Europe Huntington's Disease Therapeutics Market Share by Product
Table Europe Huntington's Disease Therapeutics Sales by End User (2014-2019) (K MT)
Table Europe Huntington's Disease Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Europe Huntington's Disease Therapeutics Market Share by End User
Figure Asia Pacific Huntington's Disease Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Huntington's Disease Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Huntington's Disease Therapeutics Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Countries
Table Asia Pacific Huntington's Disease Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Huntington's Disease Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Huntington's Disease Therapeutics Revenue Market Share by Countries
Figure China Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure China Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Japan Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Korea Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure India Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Australia Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Huntington's Disease Therapeutics Sales by Product (2014-2019) (K MT)
Table Asia Pacific Huntington's Disease Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Huntington's Disease Therapeutics Market Share by Product
Table Asia Pacific Huntington's Disease Therapeutics Sales by End User (2014-2019) (K MT)
Table Asia Pacific Huntington's Disease Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Huntington's Disease Therapeutics Market Share by End User
Figure Central & South America Huntington's Disease Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Huntington's Disease Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Huntington's Disease Therapeutics Sales by Countries (2014-2019) (K MT)
Table Central & South America Huntington's Disease Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Huntington's Disease Therapeutics Sales Market Share by Countries
Table Central & South America Huntington's Disease Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Huntington's Disease Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Huntington's Disease Therapeutics Revenue Market Share by Countries
Figure Brazil Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Huntington's Disease Therapeutics Sales by Product (2014-2019) (K MT)
Table Central & South America Huntington's Disease Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Huntington's Disease Therapeutics Market Share by Product
Table Central & South America Huntington's Disease Therapeutics Sales by End User (2014-2019) (K MT)
Table Central & South America Huntington's Disease Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Huntington's Disease Therapeutics Market Share by End User
Figure Middle East and Africa Huntington's Disease Therapeutics Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Huntington's Disease Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Huntington's Disease Therapeutics Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Countries
Table Middle East and Africa Huntington's Disease Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Huntington's Disease Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Huntington's Disease Therapeutics Revenue Market Share by Countries
Figure GCC Countries Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Huntington's Disease Therapeutics Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Huntington's Disease Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Huntington's Disease Therapeutics Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Huntington's Disease Therapeutics Market Share by Product
Table Middle East and Africa Huntington's Disease Therapeutics Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Huntington's Disease Therapeutics Market Share by End User
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table H. Lundbeck Company Details
Table H. Lundbeck Huntington's Disease Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table H. Lundbeck Recent Development
Table Prana Biotechnology Company Details
Table Prana Biotechnology Huntington's Disease Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Prana Biotechnology Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Horizon Pharma Company Details
Table Horizon Pharma Huntington's Disease Therapeutics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Horizon Pharma Recent Development
Table Global Huntington's Disease Therapeutics Sales Forecast by Regions 2019-2025 (K MT)
Table Global Huntington's Disease Therapeutics Sales Market Share Forecast by Regions 2019-2025
Table Global Huntington's Disease Therapeutics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Huntington's Disease Therapeutics Revenue Market Share Forecast by Regions 2019-2025
Table Global Huntington's Disease Therapeutics Sales Forecast by Product 2019-2025 (K MT)
Table Global Huntington's Disease Therapeutics Sales Market Share Forecast by Product 2019-2025
Table Global Huntington's Disease Therapeutics Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Huntington's Disease Therapeutics Revenue Market Share Forecast by Product 2019-2025
Table Global Huntington's Disease Therapeutics Sales Forecast by End User 2019-2025 (K MT)
Table Global Huntington's Disease Therapeutics Sales Market Share Forecast by End User 2019-2025
Figure North America Huntington's Disease Therapeutics Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Huntington's Disease Therapeutics Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Huntington's Disease Therapeutics Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Huntington's Disease Therapeutics Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Huntington's Disease Therapeutics Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Huntington's Disease Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Huntington's Disease Therapeutics Value Chain
Table Huntington's Disease Therapeutics Customers List
Table Huntington's Disease Therapeutics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Huntington's Disease Therapeutics Market Professional Survey Report 2019
    Published: 27-Sep-2019        Price: US 3500 Onwards        Pages: 106
    Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease. The demand for Huntington's disease (HD) therapeutics as one......
  • Global (United States, European Union and China) Huntington's Disease Therapeutics Market Research Report 2019-2025
    Published: 01-Aug-2019        Price: US 3280 Onwards        Pages: 113
    Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease. The demand for Huntington's disease (HD) therapeutics as one......
  • Global Huntington'S Disease Therapeutics Industry Market Research Report
    Published: 25-Jun-2019        Price: US 2960 Onwards        Pages: 114
    The Huntington'S Disease Therapeutics market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Huntington'S Disease Therapeutics industrial chain, this report mainly elaborates the definition, types, applications and major players of Huntington'S Disease Therapeutics market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and di......
  • Global Huntington's Disease Therapeutics Market Insights, Forecast to 2025
    Published: 31-May-2019        Price: US 3900 Onwards        Pages: 115
    Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease. The demand for Huntington's disease (HD) therapeutics as one......
  • Global Huntington's Disease Therapeutics Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2024
    Published: 14-May-2019        Price: US 2600 Onwards        Pages: 149
    In this report, we analyze the Huntington's Disease Therapeutics industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019.......
  • Global Huntington's Disease Therapeutics Market Research Report 2019
    Published: 13-Mar-2019        Price: US 2900 Onwards        Pages: 93
    Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease. The demand for Huntington's disease (HD) therapeutics as one......
  • Huntington's Disease - Epidemiology Forecast to 2028
    Published: 15-Jan-2019        Price: US 3250 Onwards        Pages: 50
    DelveInsight's "Huntington's Disease - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Huntington's Disease epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2028 Huntington's Disease Epidemiology The epidemiology......
  • Huntington's Disease - Market Insight, Epidemiology and Market Forecast - 2028
    Published: 15-Jan-2019        Price: US 6250 Onwards        Pages: 100
    DelveInsight's "Huntington's Disease - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Huntington's Disease epidemiology and market outlook for the 7MM. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2028 Huntington's Disease Understanding and Treatment Algorithm The market report provides the overvi......
  • Global Huntington's Disease Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Jan-2019        Price: US 3480 Onwards        Pages: 120
    Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease. Scope of the Report: This report focuses on t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs